The role of vitamin D in H1N1 influenza and SARS-CoV-2 infection

NewsGuard 100/100 Score

Low vitamin D levels lead to poor outcomes following acute respiratory infection (e.g., influenza). This is why high doses of vitamin D supplements have been recommended to reduce the severity of seasonal influenza. During the ongoing coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), scientists renewed their interest in studying the role of vitamin D in protecting individuals from severe infection.

Study: Vitamin D and the ability to produce 1,25(OH)2D are critical for protection from viral infection of the lungs. Image Credit: Adisak Riwkratok/Shutterstock
Study: Vitamin D and the ability to produce 1,25(OH)2D are critical for protection from viral infection of the lungs. Image Credit: Adisak Riwkratok/Shutterstock

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Background

Previous studies have shown that vitamin D supplementation is beneficial for treating COVID-19. These studies have shown that low levels of vitamin D circulation (serum 25(OH)D, 25D) were correlated with a high mortality rate among COVID-19 patients.

Scientists reported that vitamin D and the active form of vitamin D (1,25(OH)2D, 1,25D) play a significant role in the anti-viral response. However, the extent of the effect may vary with different viruses. A previous in vitro study revealed that 1,25D treatment of T cells from individuals infected with human immunodeficiency virus (HIV) showed a significant decrease in viral RNA transcription by direct decrease of NF-kB, which reactivates proviral HIV. However, similar in vitro treatment on epithelial cells of patients infected with respiratory syncytial virus (RSV) did not affect viral replication.

Scientists revealed that the production of cytokines (e.g., TNFa, IL-5, IL-1b, IL-6, IL-10 and type I interferons) and antimicrobial peptides (e.g., cathelicidin, b-defensin, etc.,) at mucosal surface play an important role in the innate immune response against viruses. Many studies have reported that 1,25D and other vitamin D analogs induce the production of cathelicidin in response to viral infection.

Since studies have reported that cathelicidin LL-37 can effectively kill viruses, such as influenza, researchers believe it could also inhibit the SARS-CoV-2 virus. Another important attribute of 1,25D is that it reduces IFNg, IL-6, and TNF levels and restricts inflammatory responses.

Research has also shown that vitamin D targets lung epithelial cells due to the presence of vitamin D receptors (VDR). A previous study using a mice model demonstrated that mice treated with 1,25D precursors were also protected from subsequent H1N1 influenza infection.

About the study

Using animal models, a new study posted to the bioRxiv* preprint server focused on determining Vitamin D's role in SARS-CoV-2 and H1N1 influenza. In this study, researchers determined the effect of vitamin D supplements on the lung anti-viral response in animal models.

The current study utilized two animal models, i.e., mice and hamsters. The experimental findings from both the animal models suggested that vitamin D supplements effectively reduced lung inflammation following SARS-CoV-2 and H1N1 influenza infection.

Scientists found that D- mice had lung infections even without viral infection. A previous study by the same group of researchers reported that feeding D- diets to mice inhibited the production of 1,25D (Cyp KO), which resulted in severe vitamin D deficiency. The current study reported severe influenza infection in D- Cyp KO, while minimal infection was observed in D+ WT mice.

The authors reported that following influenza infection, the survival of D+ Cyp KO mice was significantly less compared to D+ WT mice. Similarly, researchers observed that the introduction of vitamin D supplement significantly lowered lung inflammation and Ifnb expression in the lung of mice after SARS-CoV-2 infection.  

Scientists observed that vitamin D treatments did not show any effect on the expression of viral RNA (SARS-CoV-2 or H1N1 influenza) in the lungs of both hamsters and mice. However, it controlled the hosts’ inflammatory response to viruses in the lungs. 

A high dose of vitamin D treatment (D++) exhibited a similar level of protection from SARS-CoV-2 in mice. Additionally, 25D treatment supported a faster recovery in SARS-CoV-2 infected mice. The finding of this study is supported by previous studies that reported 25D treated mice exhibited a reduction in lung inflammation. However, vitamin D treatment showed an insignificant effect on weight loss and lethality following H1N1 infection.

Researchers reported that SARS-CoV-2 infection-induced Cyp27B1 and Cyp24A1 in the lungs of mice infected with SARS-CoV-2. The current study stated that the ability of the host to produce Cyp27B1 is essential for the survival of mice with H1N1 infection. The dietary supplements, i.e., only a high dose of vitamin D supplement (D++), increased the concentration of 25D in serum.

Conclusion

The study's results strongly indicated that vitamin D and 1,25D treatment could effectively protect the lungs from COVID-19 infection. More clinical studies are required to understand better the underlying mechanism by which vitamin D regulates anti-viral response in the lungs.

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Journal references:

Article Revisions

  • Feb 22 2023 - The preprint preliminary research paper that this article was based upon was accepted for publication in a peer-reviewed Scientific Journal. This article was edited accordingly to include a link to the final peer-reviewed paper, now shown in the sources section.
Dr. Priyom Bose

Written by

Dr. Priyom Bose

Priyom holds a Ph.D. in Plant Biology and Biotechnology from the University of Madras, India. She is an active researcher and an experienced science writer. Priyom has also co-authored several original research articles that have been published in reputed peer-reviewed journals. She is also an avid reader and an amateur photographer.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Bose, Priyom. (2023, February 22). The role of vitamin D in H1N1 influenza and SARS-CoV-2 infection. News-Medical. Retrieved on April 19, 2024 from https://www.news-medical.net/news/20220704/The-role-of-vitamin-D-in-H1N1-influenza-and-SARS-CoV-2-infection.aspx.

  • MLA

    Bose, Priyom. "The role of vitamin D in H1N1 influenza and SARS-CoV-2 infection". News-Medical. 19 April 2024. <https://www.news-medical.net/news/20220704/The-role-of-vitamin-D-in-H1N1-influenza-and-SARS-CoV-2-infection.aspx>.

  • Chicago

    Bose, Priyom. "The role of vitamin D in H1N1 influenza and SARS-CoV-2 infection". News-Medical. https://www.news-medical.net/news/20220704/The-role-of-vitamin-D-in-H1N1-influenza-and-SARS-CoV-2-infection.aspx. (accessed April 19, 2024).

  • Harvard

    Bose, Priyom. 2023. The role of vitamin D in H1N1 influenza and SARS-CoV-2 infection. News-Medical, viewed 19 April 2024, https://www.news-medical.net/news/20220704/The-role-of-vitamin-D-in-H1N1-influenza-and-SARS-CoV-2-infection.aspx.

Comments

  1. Jennifer Salem Riambon Jennifer Salem Riambon Canada says:

    We knew it from the beginning, why was there no massive campaign during the start of pandemic?

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Link between nutrient intake and multimorbidity risk reported in recent study, more research is needed